Status:
RECRUITING
Prevalence of Long COVID-19 in the Canary Islands
Lead Sponsor:
University of Las Palmas de Gran Canaria
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
With more than 246 million people diagnosed with coronavirus 2019 (COVID-19) around the world, many of whom have required medical attention for past 23 months, greater emphasis is being placed on post...
Detailed Description
It is intended to develop a Cross-sectional Descriptive Observational Study. The investigation will be carried out following the guidelines of "Strengthening the Reporting of Observational Studies in ...
Eligibility Criteria
Inclusion
- Have been positive for COVID-19 since the declaration of the state of alarm throughout the Spanish territory to deal with the health emergency situation caused by COVID-19 (March 14, 2020).
- Symptoms associated with COVID-19 at least after 12 weeks of its detection.
- Adequate cognitive and physical level to understand and perform the tests evaluation.
Exclusion
- Present comorbidities prior to suffering from COVID-19 whose symptoms are resemble Post-acute COVID-19.
- Fibromyalgia.
- Chronic fatigue.
- Neuromuscular disease.
- Not having signed the informed consent.
- Person undergoing treatment for active cancer.
Key Trial Info
Start Date :
March 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05228691
Start Date
March 22 2022
End Date
May 1 2026
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Las Palmas de Gran Canaria
Las Palmas de Gran Canaria, Las Palmas, Spain, 35016